<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2024.13237</article-id>
<article-id pub-id-type="publisher-id">MMR-30-1-13237</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] MicroRNA‑219 is downregulated in non‑small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Sun</surname><given-names>Xiaoping</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Min</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Haiyan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Ming</surname><given-names>Kunxiu</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>07</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>05</month>
<year>2024</year></pub-date>
<volume>30</volume>
<issue>1</issue>
<elocation-id>113</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2024 Sun et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Mol Med Rep 16: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="16" page="3557" id="RA1" xlink:href="10.3892/mmr.2017.7000" ext-link-type="doi">3557&#x2013;3564</related-article>, 2017; DOI: 10.3892/mmr.2017.7000</p>
<p>Following the publication of this paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Figs. 2C and 4C were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Yang S, Zhang Y, Zhao X, Wang J and Shang J: microRNA-361 targets Wilms&#x2019; tumor 1 to inhibit the growth, migration and invasion of non-small-cell lung cancer cells. Mol Med Rep 14: 5415&#x2013;5421, 2016].</p>
<p>Owing to the fact that the contentious data in the above article had already been published prior to its submission to <italic>Molecular Medicine Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
